Polyethylene glycol 3350 and Depression - a phase IV clinical study of FDA data

Summary:

Depression is found among people who take Polyethylene glycol 3350, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Polyethylene glycol 3350 and have Depression. It is created by eHealthMe based on reports of 1,512 people who have side effects when taking Polyethylene glycol 3350 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

1,512 people reported to have side effects when taking Polyethylene glycol 3350.
Among them, 15 people (0.99%) have Depression.

What is Polyethylene glycol 3350?

Polyethylene glycol 3350 has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 1,636 Polyethylene glycol 3350 users for its effectiveness, alternative drugs and more.

What is Depression?

Depression is found to be associated with 4,092 drugs and 3,977 conditions by eHealthMe.

Number of Polyethylene glycol 3350 and Depression reports submitted per year:

Could Polyethylene glycol 3350 cause Depression?

Time on Polyethylene glycol 3350 when people have Depression *:

Gender of people who have Depression when taking Polyethylene glycol 3350 *:

female: 84.62 %
male: 15.38 %

Age of people who have Depression when taking Polyethylene glycol 3350 *:

Common drugs people take besides Polyethylene glycol 3350 *:

Common side effects people have besides Depression *:

Stress And Anxiety: 8 people, 53.33%
High Blood Pressure: 7 people, 46.67%
Weight Decreased: 7 people, 46.67%
Weakness: 7 people, 46.67%
Feeling Abnormal: 7 people, 46.67%
Dizziness: 7 people, 46.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 46.67%
Nausea (feeling of having an urge to vomit): 7 people, 46.67%
Micturition Urgency (urgency to pass the urine): 6 people, 40.00%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 40.00%

Common conditions people have *:

Nausea (feeling of having an urge to vomit): 6 people, 40.00%
Erdheim-Chester Disease (abnormal multiplication of a specific type of white blood cells): 5 people, 33.33%
Pain: 3 people, 20.00%
Cystic Fibrosis (disease of the secretary glands): 3 people, 20.00%
High Blood Pressure: 2 people, 13.33%
Type 2 Diabetes: 1 person, 6.67%
Cardiac Failure: 1 person, 6.67%
Diabetes: 1 person, 6.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 6.67%
Blast Crisis In Myelogenous Leukaemia: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Polyethylene glycol 3350 and have Depression?

Check whether Depression is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

Related studies

Common Polyethylene glycol 3350 side effects:

Browse all side effects of Polyethylene glycol 3350:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Depression treatments and more:

Depression (598,227 reports)

COVID vaccines that are related to Depression:

Common drugs associated with Depression:

All the drugs that are associated with Depression:

Depression (4,092 drugs)

Common conditions associated with Depression:

Multiple sclerosis: 20,384 reports
Pain: 12,961 reports
High blood pressure: 10,315 reports
Rheumatoid arthritis: 10,067 reports
Stress and anxiety: 9,456 reports

All the conditions that are associated with Depression:

Depression (3,977 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Polyethylene glycol 3350) and Polyethylene glycol 3350 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.